5-bisphosphate 3-kinase Catalytic Subunit Alpha Isoform Uses, Dosage, Side Effects and more
5-bisphosphate 3-kinase Catalytic Subunit Alpha Isoform is under investigation in clinical trial NCT02957266 (Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy).
| Attribute | Details |
|---|---|
| Trade Name | 5-bisphosphate 3-kinase Catalytic Subunit Alpha Isoform |
| Generic | PIK3CA |
| PIK3CA Other Names | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, PIK3CA |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
